DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
6.93
+0.78 (12.68%)
At close: Jun 26, 2026, 4:00 PM EDT
7.03
+0.10 (1.44%)
After-hours: Jun 26, 2026, 4:04 PM EDT
DarioHealth Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DarioHealth stock have an average target of 10.5, with a low estimate of 10 and a high estimate of 11. The average target predicts an increase of 51.52% from the current stock price of 6.93.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for DarioHealth stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $10 | Buy | Maintains | $10 | +44.30% | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $11 | Hold | Maintains | $11 | +58.73% | May 13, 2026 |
Financial Forecast
Revenue This Year
26.16M
from 22.36M
Increased by 17.00%
Revenue Next Year
38.23M
from 26.16M
Increased by 46.13%
EPS This Year
-2.81
from -7.33
EPS Next Year
-0.68
from -2.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.0M | 40.5M | |
| Avg | 26.2M | 38.2M | |
| Low | 25.5M | 34.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.8% | 54.9% | |
| Avg | 17.0% | 46.1% | |
| Low | 13.9% | 30.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.76 | -0.57 | |
| Avg | -2.81 | -0.68 | |
| Low | -2.86 | -0.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.